We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Multi-Parameter Desktop Analyzer Provides Rapid Testing

By HospiMedica staff writers
Posted on 07 May 2007
A multi-parameter desktop analyzer has been launched for providing rapid testing at point-of-care.

Axis-Shield UK (Cambridge, UK) has launched the Afinion, a winner at the Medical Design Excellence Awards 2006, which enables immediate rapid testing, regardless of sample type. More...
Unlike many other systems currently on the market, Afinion is a genuine multi-assay analyzer, offering a wide range of laboratory-quality tests on a single point-of-care system. Afinion is well suited to multi-user environments, such as community clinics, where test results are required quickly and a laboratory service may not be available. The instrument is extremely easy to operate--users simply insert a cartridge and follow the prompts on the color touch-screen display. Minimal maintenance is required.

Tests already available on Afinion include glycated hemoglobin (HbA1c), C-reactive protein (CRP), with albumin creatinine ratio (ACR) and prothrombin time international normalized ratio (PT-INR) in the final stages of development. Other tests such as homocysteine will be introduced later.

HbA1c is used for monitoring of diabetes and is the parameter of choice for long-term glycemic (blood sugar) control. Afinion will provide results automatically in just three minutes, offering real time savings to the busy healthcare professional. CRP is used as a diagnostic tool for differentiation between viral and bacterial infections. A rapid CRP test is valuable in avoiding the prescription of antibiotics if an infection is likely to have a viral cause.


Related Links:
Axis-Shield UK

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Cardiograph Device
PageWriter TC35
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.